130 related articles for article (PubMed ID: 38010775)
1. Fasting blood glucose predicts high risk of in-stent restenosis in patients undergoing primary percutaneous coronary intervention: a cohort study.
Chen GC; Huang X; Ruan ZB; Zhu L; Wang MX; Lu Y; Tang CC
Scand Cardiovasc J; 2023 Dec; 57(1):2286885. PubMed ID: 38010775
[No Abstract] [Full Text] [Related]
2. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
4. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
Zhang J; Zhang Q; Zhao K; Bian YJ; Liu Y; Xue YT
Medicine (Baltimore); 2022 Nov; 101(47):e31707. PubMed ID: 36451388
[TBL] [Abstract][Full Text] [Related]
6. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
Wang X; Zhang M; Cheng J; Zhou H
BMC Cardiovasc Disord; 2022 Aug; 22(1):355. PubMed ID: 35927634
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
[TBL] [Abstract][Full Text] [Related]
8. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
9. Systemic immune inflammation index and its implication on in-stent restenosis among patients with acute coronary syndrome.
Ösken A; Polat F; Çakir B; Zengin A; Çalik AN; Ünal Dayi Ş; Çam N
Coron Artery Dis; 2024 May; 35(3):209-214. PubMed ID: 38180335
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Percutaneous Coronary Intervention for In-Stent Restenosis Versus De Novo Lesions: A Meta-Analysis.
Elbadawi A; Dang AT; Mahana I; Elzeneini M; Alonso F; Banerjee S; Kumbhani DJ; Elgendy IY; Mintz GS
J Am Heart Assoc; 2023 Jul; 12(13):e029300. PubMed ID: 37382147
[TBL] [Abstract][Full Text] [Related]
11. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
13. Impact of anemia on in-stent restenosis after percutaneous coronary intervention.
Hu H; Wang S; Tang G; Zhai C; Shen L
BMC Cardiovasc Disord; 2021 Nov; 21(1):548. PubMed ID: 34798833
[TBL] [Abstract][Full Text] [Related]
14. [Effects of miRNA-1,miRNA-21 in plasma on in-stent restenosis in patients with coronary heart disease and diabetes mellitus after percutaneous coronary intervention].
Guan JJ; Zhang Y; Liu YJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr; 34(4):304-308 384. PubMed ID: 30788936
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
Xie F; Yu Z; Xiong Y; Wu Z; Wu Y
Eur J Med Res; 2024 Feb; 29(1):145. PubMed ID: 38409069
[TBL] [Abstract][Full Text] [Related]
17. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Management and Outcomes of Percutaneous Coronary Intervention for Coronary In-Stent Restenosis: Insights From the France PCI Registry.
Duband B; Souteyrand G; Clerc JM; Chassaing S; Fichaux O; Marcollet P; Deballon R; Roussel L; Pereira B; Collet JP; Commeau P; Cayla G; Koning R; Motreff P; Benamer H; Rangé G
Cardiovasc Revasc Med; 2023 Jul; 52():39-46. PubMed ID: 36813696
[TBL] [Abstract][Full Text] [Related]
19. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Li S; Luo C; Chen H
Medicine (Baltimore); 2021 Apr; 100(15):e25484. PubMed ID: 33847656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
